08/05/2007...

08/05/2007 2:15PM

http://imagesignal.comsec.com.au/asxdata/20070508/pdf/00719123.pdf

Prana Biotechnology to Present at the
Acumen BioFin/Rodman & Renshaw Fourth Annual
Global Healthcare Conference
MELBOURNE, Australia ? May 8, 2007 ? Prana Biotechnology Limited (NASDAQ: PRAN / ASX:
PBT), a biopharmaceutical company focused on the research and development of treatments for
neurodegenerative disorders, today announced that Craig W. Ritchie, MD, Chief European Clinical
Advisor, will present at the Acumen BioFin/Rodman & Renshaw Fourth Annual Global Healthcare
Conference in Monaco on Tuesday, May 15 at 10.25 CET (18.25 Melbourne/Sydney time and 4:25
a.m. EST in New York). The Conference will be held on May 14 - 15 at Le Meridien Beach Plaza
Hotel at the Sea Club.
During the presentation, Dr. Ritchie will address the current status of Prana?s development program.
Dr. Ritchie?s presentation will be web cast live and a replay will be available following the conclusion.
To access the live and encore presentations, visit the Prana web site, www.pranabio.com. The
presentation will be archived on the Company site for 30 days.
About Prana Biotechnology Limited
Prana Biotechnology was established to commercialise research into Alzheimer's disease and other
major age-related neurodegenerative disorders. The company was incorporated in 1997 and listed
on the Australian Stock Exchange in March 2000 and listed on NASDAQ in September 2002.
Researchers at prominent international institutions including The University of Melbourne, The
Mental Health Research Institute (Melbourne) and Massachusetts General Hospital, a teaching
hospital of Harvard Medical School, contributed to the discovery of Prana?s technology.
For further information, please visit our web site at www.pranabio.com.
Contacts:
Investor and media relations
Rebecca Piercy
Buchan Consulting
T: 02 9237 2800/0422 916 422
E: [email protected]